The PGT Healthcare ( partnership between Teva and Procter & Gamble has been terminated after seven years. The collaboration was focused on the joint market of OTC medicines; the separation should become effective since July 1, 2018. The decision, according to Teva, is due to no longer closely aligned priorities and strategies of the two partners. Each company will now take back its own brand and product assets to re-establish independent OTC businesses.